PDF icon Download PDF
Int J Angiol
DOI: 10.1055/a-2645-2283
Review Article

Coronary Intervention: History and Current Status

Catherine R. Glazier
1   Department of Medicine, Royal Devon and Exeter Hospital, Exeter, United Kingdom
,
James J. Glazier 
2   Department of Medicine, Wayne State University, Detroit, Michigan
3   Department of Cardiology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan
› Author Affiliations
Funding None.
› Further Information
   Permissions and Reprints
Preview

Abstract

On September 16, 1977, Dr Andreas Roland Grüntzig performed the world's first successful percutaneous transluminal coronary angioplasty at the University Hospital Zurich, Switzerland. This spectacular event ushered in the era of interventional cardiology. The technique has had a major influence on the practice of cardiology, right up to the current day. While Grüntzig remains the undisputed father of interventional cardiology, the observations and techniques developed by preceding pioneers in the fields of angiology, radiology, cardiology, and vascular and cardiac surgery paved the way for this procedure. Coronary stents were first developed by Ulrich Sigwart and his team in Lausanne, Switzerland. The aim of the stents was to reduce the considerable rates of restenosis and abrupt closure associated with balloon angioplasty. Current second-generation drug-eluting stents have very low abrupt closure and restenosis rates. Drug-eluting stents have performed favorably when compared with coronary artery bypass surgery in the treatment of patients with complex coronary artery disease. It is estimated that, in approximately one-third of such patients, treatment with these stents is an excellent alternative to coronary artery bypass surgery. Currently, coronary angioplasty with drug-eluting stents remains the preferred treatment of acute myocardial infarction, provided this can be done in timely fashion. With regard to patients with acute coronary syndrome, the benefit for angioplasty is greatest for those patients at moderate to high risk for cardiac complications. It is now accepted that most patients with stable ischemic heart disease are best managed with medical treatment rather than angioplasty.

Keywords

coronary artery disease - percutaneous transluminal coronary angioplasty - coronary stents - drug-coated balloons - intravascular ultrasound - intravascular lithotripsy - Dotter technique

Authors' Contributions

All authors had access to the data and a role in writing the manuscript.




Publication History

Article published online:
23 July 2025

© 2025. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA